Abstract:Iron is an essential mineral participating in numerous biological processes in the organism under physiological conditions. However, it may be also involved in the pathological mechanisms activated in various cardiovascular diseases including myocardial ischemia/reperfusion (I/R) injury, due to its involvement in reactive oxygen species (ROS) production. Furthermore, iron has been reported to participate in the mechanisms of iron-dependent cell death defined as "ferroptosis". On the other hand, iron may be also involved in the adaptive processes of ischemic preconditioning (IPC). This study aimed to elucidate whether small amounts of iron may modify the cardiac response to I/R in isolated perfused rat hearts and their protection by IPC. Pretreatment of the hearts with iron nanoparticles 15 min prior to sustained ischemia (iron preconditioning, Fe-PC) did not attenuate post-I/R contractile dysfunction. Recovery of left ventricular developed pressure (LVDP) was significantly improved only in the group with combined pretreatment with iron and IPC. Similarly, the rates of contraction and relaxation [+/-(dP/dt)max] were almost completely restored in the group preconditioned with a combination of iron and IPC but not with iron alone. In addition, the severity of reperfusion arrhythmias was reduced only in the iron+IPC group. No changes in protein levels of "survival" kinases of the RISK pathway (Reperfusion Injury Salvage Kinase) were found except for reduced caspase 3 levels in both preconditioned groups. The results indicate that a failure to precondition rat hearts with iron may be associated with the absent upregulation of RISK proteins and the pro-ferroptotic effect manifested by reduced glutathione peroxidase 4 (GPX4) levels. However, combination with IPC suppressed the negative effects of iron resulting in cardioprotection.

Cardioprotective Activity of Iron Oxide Nanoparticles

Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells.

Iron oxide nanoparticles: A promising approach for diagnosis and treatment of cardiovascular diseases

Effects of Iron Nanoparticles Administration on Ischemia/Reperfusion Injury in Isolated Hearts of Male Wistar Rats

Deciphering Active Biocompatibility of Iron Oxide Nanoparticles from Their Intrinsic Antagonism

Co-loading Antioxidant N-acetylcysteine Attenuates Cytotoxicity of Iron Oxide Nanoparticles in Hypoxia/reoxygenation Cardiomyocytes

Iron Oxide Nanoparticles: Magnetic and Biological Properties

Iron/iron Oxide Nanoparticles: Advances in Microbial Fabrication, Mechanism Study, Biomedical, and Environmental Applications

Targeting Ferroptosis by Polydopamine Nanoparticles Protects Heart against Ischemia/Reperfusion Injury

Effects of 2,3-dimercaptosuccinic acid modified Fe2O3 nanoparticles on microstructure and biological activity of cardiomyocytes

Long-term Pulmonary Iron Oxide Nanoparticles Exposure Disrupts Hepatic Iron-Lipid Homeostasis and Increases Plaque Vulnerability in ApoE-/- Mice

Research on Nanotoxicity of an Iron Oxide Nanoparticles and Potential Application

Recent Progress in the Effect of Magnetic Iron Oxide Nanoparticles on Cells and Extracellular Vesicles

Dual Enzyme-Like Activities of Iron Oxide Nanoparticles and Their Implication for Diminishing Cytotoxicity

An enhanced cardio-protective effect of nanoparticles loaded with active components from Polygonum orientale L. against isoproterenol-induced myocardial ischemia in rats

Natural polyphenol-based nanoparticles for the treatment of iron-overload disease

Effects of Different Doses of 2,3-Dimercaptosuccinic Acid-Modified Fe2 O3 Nanoparticles on Intercalated Discs in Engineered Cardiac Tissues.

Iron-bearing Nanoparticles Trigger Human Umbilical Vein Endothelial Cells Ferroptotic Responses by Promoting Intracellular Iron Level

Ferrous Oxide Nanoparticles Induced Abnormal Cardiac Development in Zebrafish Through Hypoxia and Ferroptosis

Strategy to Prevent Cardiac Toxicity Induced by Polyacrylic Acid Decorated Iron MRI Contrast Agent and Investigation of Its Mechanism

In vivo cardioprotective effect of zinc oxide nanoparticles against doxorubicin-induced myocardial infarction by enhancing the antioxidant system and nitric oxide production